Approvals/CIMA-AEMPS/SERETIDE ACCUHALER 50 MICROGRAMOS/500 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN

Approved

STANDARD

SERETIDE ACCUHALER 50 MICROGRAMOS/500 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a6aebc6630e160ed
Drug Cima Aemps Name: SERETIDE ACCUHALER 50 MICROGRAMOS/500 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN
Register Number: 8326IP
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2023-11-08
Dosage Form: POLVO PARA INHALACIÓN
Dose: 50/500 mcg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

FLUTICASONA PROPIONATO

0.5 mg

SALMETEROL

0.047 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 8, 2023

Approval ID

a6aebc6630e160ed

Type

Standard